Some examples and use cases from the internet:

Some examples and use cases from the internet:

• The opinion noted that the mouse bioassay (MBA) currently used for detection of lipophilic biotoxins 'has shortcomings and is not considered an appropriate tool for control purposes because of the high variability in results, the insufficient detection capability and the limited specificity'.
• The distribution of the medicinal product in the target animal shall be described; the possibility of plasma protein binding, or passage into milk or eggs and of the accumulation of lipophilic compounds shall be considered.
• Because of its lipophilic nature, mitotane is not likely to be dialysable.
• The specific migration of lipophilic substances in mg/kg (M) shall be corrected by the FRF variable between 1 and 5 (MFRF).
• life and the lipophilic nature of mitotane, it may take weeks to return to normal.
• The specific migration of lipophilic substances into simulant D and its substitutes shall be corrected by the following factors:
• The distribution of the veterinary medicinal product in the target animal shall be described; the possibility of plasma protein binding or passage into milk or eggs and of the accumulation of lipophilic compounds shall be considered.
• The patient should be followed closely, taking into account that impairment is reversible, but given the long half

• The specific migration of lipophilic substances into simulant D and its substitutes shall be corrected by the following factors:
• The opinion noted that the mouse bioassay (MBA) currently used for detection of lipophilic biotoxins 'has shortcomings and is not considered an appropriate tool for control purposes because of the high variability in results, the insufficient detection capability and the limited specificity'.
• The mouse bioassay (MBA) and the rat bioassay (RBA) are the official methods for the detection of lipophilic biotoxins.
• Any other recognised method, different from the liquid chromatography (LC) mass spectrometry (MS), could be applied for the detection of lipophilic toxins provided that they fulfil the method performance criteria stipulated by the EU
• The specific migration of lipophilic substances in mg/kg (M) shall be corrected by the FRF variable between 1 and 5 (MFRF).
• The distribution of the veterinary medicinal product in the target animal shall be described; the possibility of plasma protein binding or passage into milk or eggs and of the accumulation of lipophilic compounds shall be considered.
• RL.
• The distribution of the medicinal product in the target animal shall be described; the possibility of plasma protein binding, or passage into milk or eggs and of the accumulation of lipophilic compounds shall be considered.